| PTO Form 1963 (Rev 5/2006) |
| OMB No. 0651-0055 (Exp 12/31/2011) |
Combined Declaration of Use In Commerce & Application For Renewal of Registration of A Mark Under Sections 8 & 9
The table below presents the data as entered.
Input Field
|
Entered
|
| REGISTRATION NUMBER |
1447100 |
| REGISTRATION DATE |
07/14/1987 |
| SERIAL NUMBER |
73635694 |
| MARK SECTION |
| MARK |
ZESTRIL |
| OWNER SECTION (current) |
| NAME |
IMPERIAL CHEMICAL INDUSTRIES PLC |
| STREET |
IMPERIAL CHEMICAL HOUSE |
| CITY |
MILLBANK, LONDON |
| ZIP/POSTAL CODE |
SW1P3JF |
| COUNTRY |
United Kingdom |
| OWNER SECTION (proposed) |
| NAME |
AstraZeneca UK Limited by assignment from Zeneca Limited reel/frame 2231/0431 and previous assignment from Imperial Chemical Industries PLC
reel/frame 1091/0213 |
| STREET |
15 Stanhope Gate |
| CITY |
London |
| ZIP/POSTAL CODE |
W1Y6LN |
| COUNTRY |
United Kingdom |
| EMAIL |
XXXX |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| ATTORNEY SECTION (current) |
| NAME |
JOHN M. SHEEHAN |
| FIRM NAME |
LAW DEPARTMENT |
| INTERNAL ADDRESS |
CONCORD PIKE & NEW MURPHY RD. |
| STREET |
ICI AMERICAS INC. |
| CITY |
WILMINGTON |
| STATE |
Delaware |
| POSTAL CODE |
19897 |
| COUNTRY |
United States |
| ATTORNEY SECTION (proposed) |
| NAME |
Wm. Charles Saunders |
| FIRM NAME |
AstraZeneca Pharmaceuticals LP |
| INTERNAL ADDRESS |
OW2 |
| STREET |
1800 Concord Pike |
| CITY |
WILMINGTON |
| STATE |
Delaware |
| POSTAL CODE |
19850 |
| COUNTRY |
United States |
| PHONE |
3028854268 |
| FAX |
3028868221 |
| EMAIL |
trademarks@astrazeneca.com |
| AUTHORIZED TO COMMUNICATE VIA E-MAIL |
Yes |
| ATTORNEY DOCKET NUMBER |
ZESTRIL |
| GOODS AND/OR SERVICES SECTION |
| INTERNATIONAL CLASS |
005 |
| GOODS OR SERVICES |
KEEP ALL LISTED |
| SPECIMEN FILE NAME(S) |
\\TICRS2\EXPORT13\736\356 \73635694\xml2\S890002.JP G |
| SPECIMEN DESCRIPTION |
label for the product |
| PAYMENT SECTION |
| NUMBER OF CLASSES |
1 |
| NUMBER OF CLASSES PAID |
1 |
| SUBTOTAL AMOUNT |
500 |
| TOTAL FEE PAID |
500 |
| SIGNATURE SECTION |
| SIGNATURE |
/wcs/ |
| SIGNATORY'S NAME |
Wm. Charles Saunders |
| SIGNATORY'S POSITION |
Sr. Trademark Attorney |
| DATE SIGNED |
07/31/2007 |
| PAYMENT METHOD |
DA |
| FILING INFORMATION |
| SUBMIT DATE |
Tue Jul 31 12:27:45 EDT 2007 |
| TEAS STAMP |
USPTO/S08N09-XXX.XX.XXX.X
X-20070731122745611870-14
47100-380b113c19e4a75765d
1585459df046a98-DA-6629-2
0070731103612270799 |
| PTO Form 1963 (Rev 5/2006) |
| OMB No. 0651-0055 (Exp 12/31/2011) |
Combined Declaration of Use In Commerce & Application For Renewal of Registration of A Mark Under Sections 8 & 9
To the Commissioner for Trademarks:
REGISTRATION NUMBER: 1447100
REGISTRATION DATE: 07/14/1987
MARK: ZESTRIL
The owner, AstraZeneca UK Limited by assignment from Zeneca Limited reel/frame 2231/0431 and previous assignment from Imperial Chemical Industries PLC reel/frame 1091/0213, having an address of
15 Stanhope Gate
London, W1Y6LN
United Kingdom
is filing a Combined Declaration of Use In Commerce & Application For Renewal of Registration of A Mark Under Sections 8 & 9.
For International Class 005, the mark is in use in commerce on or in connection with
all goods or services listed in the existing registration for this specific class; or, the owner is making
the listed excusable nonuse claim.
The owner is submitting one specimen showing the mark as used in commerce on or in connection with any item in this class, consisting of a(n) label for the product.
Specimen File1
The registrant hereby appoints Wm. Charles Saunders of AstraZeneca Pharmaceuticals LP
OW2
1800 Concord Pike
WILMINGTON, Delaware 19850
United States
to file this Combined Declaration of Use In Commerce & Application For Renewal of Registration of A Mark Under Sections 8 & 9 on behalf of the registrant. The attorney docket/reference
number is ZESTRIL.
A fee payment in the amount of $500 will be submitted with the form, representing payment for 1 class(es), plus any additional grace period fee, if necessary.
Declaration
Section 8: Declaration of Use in Commerce
Unless the owner has specifically claimed excusable non-use, the owner, or its related company, is using the mark in commerce on or in connection with the goods and/or services identified above,
as evidenced by the attached specimen(s) showing the mark as used in commerce.
Section 9: Application for Renewal
The registrant requests that the registration be renewed for the goods and/or services identified above.
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signature: /wcs/ Date: 07/31/2007
Signatory's Name: Wm. Charles Saunders
Signatory's Position: Sr. Trademark Attorney
Mailing Address
(current):
LAW DEPARTMENT
ICI AMERICAS INC.
WILMINGTON, Delaware 19897
Mailing Address
(proposed):
AstraZeneca Pharmaceuticals LP
1800 Concord Pike
WILMINGTON, Delaware 19850
Serial Number: 73635694
Internet Transmission Date: Tue Jul 31 12:27:45 EDT 2007
TEAS Stamp: USPTO/S08N09-XXX.XX.XXX.XX-2007073112274
5611870-1447100-380b113c19e4a75765d15854
59df046a98-DA-6629-20070731103612270799
